Wenzel, Mike
Hoeh, Benedikt
Humke, Clara
Cano Garcia, Cristina
Siech, Carolin
Steuber, Thomas
Graefen, Markus
Traumann, Miriam
Kluth, Luis
Chun, Felix K. H.
Mandel, Philipp
Funding for this research was provided by:
Universitätsklinikum Frankfurt
Article History
Received: 10 October 2024
Accepted: 18 November 2024
First Online: 28 December 2024
Declarations
:
: Financial disclosures and Conflicts of interest: Mike Wenzel receives speaker honoraria or is consultant for Accord, Johnsen&Johnsen, Pfizer, MSD, Astra Zeneca, Ipsen, Benedikt Hoeh receives speaker honoraria or is consultant for Johnsen&Johnsen and Ipsen, Thomas Steuber receives speaker honoraria or is consultant for Amgen, Astellas, Astra Zeneca, Bayer, Johnson & Johnson, MSD, Novartis, Pfizer, Proteomedics, Sanofi, Markus Graefen receives speaker honoraria or is consultant for Intuitive Surgical, Metronic, Ipsen, Astellas, Johnson & Johnson und Takeda, Felix Chun receives speaker honoraria or is consultant for Astellas, AstraZeneca, Bayer, Johnson & Johnson, Lumenis, Molecular Health, Olympus, Pfizer, Philipp Mandel receives speaker honoraria or is consultant for AMGEN, Astellas, AstraZeneca, Bayer, IPSEN, Johnson & Johnson, MSD, Novartis, Orion, Pfizer.
: Mike Wenzel receives speaker honoraria or is consultant for Accord, Johnsen&Johnsen, Pfizer, MSD, Astra Zeneca, Ipsen, Benedikt Hoeh receives speaker honoraria or is consultant for Johnsen&Johnsen and Ipsen, Thomas Steuber receives speaker honoraria or is consultant for Amgen, Astellas, Astra Zeneca, Bayer, Johnson & Johnson, MSD, Novartis, Pfizer, Proteomedics, Sanofi, Markus Graefen receives speaker honoraria or is consultant for Intuitive Surgical, Metronic, Ipsen, Astellas, Johnson & Johnson und Takeda, Felix Chun receives speaker honoraria or is consultant for Astellas, AstraZeneca, Bayer, Johnson & Johnson, Lumenis, Molecular Health, Olympus, Pfizer, Philipp Mandel receives speaker honoraria or is consultant for AMGEN, Astellas, AstraZeneca, Bayer, IPSEN, Johnson & Johnson, MSD, Novartis, Orion, Pfizer.
: No informed consent was necessary according to the approval of the study by the ethic committee.